| Not Yet Recruiting | The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Ben NCT05896956 | RenJi Hospital | — |
| Unknown | Two-in-one Covered and Uncovered Metal Stent NCT04337333 | Ajou University School of Medicine | N/A |
| Active Not Recruiting | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer NCT02293954 | City of Hope Medical Center | N/A |
| Completed | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With NCT02349412 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary NCT00987766 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Terminated | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim NCT00903396 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic NCT00919061 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That H NCT01313377 | UNICANCER | Phase 3 |
| Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gas NCT00836992 | Mayo Clinic | — |
| Completed | S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct NCT00789958 | SWOG Cancer Research Network | Phase 2 |
| Terminated | Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer NCT00658593 | NCIC Clinical Trials Group | Phase 3 |
| Completed | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer NCT00654160 | Mayo Clinic | Phase 1 |
| Terminated | Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers NCT00832637 | New Mexico Cancer Research Alliance | Phase 2 |
| Completed | Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, o NCT00513539 | University College, London | Phase 3 |
| Completed | Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pan NCT01534637 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer NCT00363584 | University Hospital Southampton NHS Foundation Trust | Phase 3 |
| Terminated | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer NCT00387348 | Massachusetts General Hospital | Phase 3 |
| Completed | Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmet NCT00304135 | Federation Francophone de Cancerologie Digestive | Phase 2 / Phase 3 |
| Completed | Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Ch NCT00262769 | University College, London | Phase 3 |
| Completed | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic C NCT00486356 | University of Nebraska | Phase 1 |
| Completed | Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer NCT00559598 | National Institutes of Health Clinical Center (CC) | — |
| Completed | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metas NCT00266097 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gal NCT00059865 | Alliance for Clinical Trials in Oncology | Phase 1 / Phase 2 |
| Completed | S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangi NCT00033540 | SWOG Cancer Research Network | Phase 2 |
| Completed | Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Bili NCT00073905 | Swiss Cancer Institute | Phase 2 |
| Completed | Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcin NCT00084942 | Roswell Park Cancer Institute | Phase 2 |
| Terminated | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract NCT00012246 | The University of Texas Medical Branch, Galveston | Phase 2 |
| Terminated | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Can NCT00030511 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, NCT00021047 | National Institutes of Health Clinical Center (CC) | Phase 1 / Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Can NCT00009893 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Withdrawn | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer NCT00588263 | Memorial Sloan Kettering Cancer Center | — |
| Completed | DX-8951f in Treating Patients With Biliary Cancer NCT00005938 | Daiichi Sankyo | Phase 2 |
| Completed | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction NCT00004910 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery NCT00004895 | Northwestern University | Phase 2 |
| Terminated | Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer NCT00005997 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas NCT00003923 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer NCT00003557 | University of Chicago | Phase 2 |
| Unknown | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct NCT00010088 | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 |
| Completed | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer NCT00003411 | University of Pittsburgh | Phase 1 |
| Completed | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lympho NCT00019513 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer NCT00003427 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestina NCT00019474 | Montefiore Medical Center | Phase 2 |
| Unknown | Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer NCT00003296 | Brown University | Phase 2 |
| Completed | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer NCT00544193 | City of Hope Medical Center | Phase 1 |
| Completed | Biological Therapy in Treating Patients With Metastatic Cancer NCT00004604 | Duke University | Phase 1 |